The ALS Ltd (ASX: ALQ) share price has come under pressure on Wednesday following the release of its half year results.
In early trade the testing services company’s shares were down as much as 4% to $9.40.
The ALS share price has recovered since then and is now down 1% to $9.69.
How did ALS perform in the first half?
For the six months ended 30 September, ALS reported an 8.7% decline in revenue from continuing operations to $838.8 million.
This was driven largely by the negative impacts of COVID-19 pandemic on its first quarter performance which led to a 9.7% decline in quarterly revenue. Pleasingly, the company’s revenues are improving, with second quarter revenue down 7.8% over the prior corresponding period.
The company’s Life Sciences business was resilient and only posted a 3.5% decline in revenue. Whereas the Commodities business reported a 13% decline in revenue and the Industrials business posted a 17.1% decline.
On the bottom line, ALS posted a statutory net profit after tax of $70.3 million. This was down 48.1% on the prior corresponding period due to one-off gains from the sale of its China business a year earlier.
On an underlying basis, the company’s net profit after tax from continuing operations was down 17.9% to $80.6 million. This excludes government subsidies and related direct costs.
The ALS board has declared an interim dividend of 8.5 cents per share fully franked. This is down from 11.5 cents per share a year earlier. Management notes that this reflects its prudent capital management strategy and demonstrates its strong liquidity position.
No guidance has been given for the full year, but management has provided an update on current trading.
It commented: “The first quarter of FY21 is expected to be the most challenging for the Group in this financial year due to economic shutdowns related to the COVID-19 pandemic. The sustained increase in global economic activity during the second quarter resulted in a significant improvement in performance across the Group. This trend has continued into early Q3.”
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
- 2 buy-rated ASX dividend shares for income investors – May 6, 2021 6:46am
- 5 things to watch on the ASX 200 on Thursday – May 6, 2021 6:17am
- 2 fantastic blue chip ASX 200 shares rated as buys – May 5, 2021 6:30pm